The impact of chronic inflammation in lung cancer is described and proved by the detection of pro-inflammatory cytokines and immune infiltrates in samples obtained by lung cancer patients, such as the detection of IL-1 like cytokines, whose expression is correlated to the activation of the inflammasome complex, in both plasma and tissues samples of lung cancer patients [88]. Here, IL1B is linked to lung carcinoma.